Valley Fever Solutions

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Our initial focus is to save and improve lives and lower the burden on caregivers, through new antifungal drugs.
Nikkomycin Z (NikZ) is fungicidal to Valley Fever (VF, coccidioidomycosis) and likely fungicidal to Candida albicans, which causes >10K US deaths annually. NikZ shows promise to be in the top 5 grossing drugs in $14B sector. Human trials can start within 12 months.
Company Type:
Privately Funded Company
Company HQ State:
Arizona
Company HQ Country:
United States
Year Founded:
2007
Main Therapeutic Focus:
Lead Product in Development:
Nikkomycin Z
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
One
Speaker
photo
President and CEO
Valley Fever Solutions